Foundation Medicine

@FoundationATCG

Changing the course of cancer with molecular information. Legal and Privacy:

Cambridge, MA
Vrijeme pridruživanja: siječanj 2013.

Tweetovi

Blokirali ste korisnika/cu @FoundationATCG

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FoundationATCG

  1. “For me as a cancer researcher, the work that we do here is really exciting. My team is able to work with genomic insights to help better understand cancer and advance research for patients. That makes our jobs even more impactful.” Learn more:

    Poništi
  2. 4. velj

    A drop in cancer death rates is in part attributed to advancements and increased use of targeted therapies. Learn how can match patients to the right targeted therapies:

    Poništi
  3. 3. velj

    Don was a member of our Patient Community Council, but more than that, he was a friend to & an advocate for so many. Don dedicated his life to helping, empowering, teaching & supporting others. Our deepest condolences to Don’s family & to all those lucky enough to have known him.

    Poništi
  4. 2. velj

    Congratulations Lisa Moren ( ) and Angela Downs for winning 's with trips to . They are raising money for research, and bringing awareness to cancer innovation, testing, and treatment.

    Poništi
  5. 30. sij

    Our 2020 summer internship applications have been posted. The Foundation Medicine internship program offers students the chance to help us transform cancer care. Jobs are available in all departments. Learn how you could make an :

    Poništi
  6. proslijedio/la je Tweet
    26. sij

    Why big pharma sees a remedy in data and AI

    Poništi
  7. 29. sij

    At , an all-day summit to empower our female colleagues, FMI’s leaders shared what looks like here, and how it enables a larger .

    Poništi
  8. 28. sij

    Existing trial models aren’t optimized for rare cancers in which <1% of patients are eligible based on the molecular driver of their cancer. Learn about SmartTrials & making clinical trial models more efficient. :

    Poništi
  9. proslijedio/la je Tweet

    program sponsor has 25 riders in Dave Bergeron and Laura Mucci’s 9 AM session! // PMC’s Billy Starr rides outside alongside other Extreme Riders

    , , i još njih 3
    Poništi
  10. proslijedio/la je Tweet

    We are kicking off Opening Ceremonies with speakers Billy Starr (), Bekah Salwasser (), Tim Murphy (), and Josh Bekenstein ( chairman of the board of trustees) ❄️ Who’s ready to ride?! 🙋🏽‍♀️🙋🏽‍♂️

    Poništi
  11. 24. sij

    At ASCO (abstract #310) A study using our CGDB in partnership with showed comprehensive genomic profiling helped better predict overall survival in HER2+ advanced gastric cancer patients who got standard treatment than IHC/ISH alone.

    Poništi
  12. 24. sij

    Our recent publication in with , & explored immuno-oncology (IO) biomarkers in three types of . The data support the inclusion of squamous-cell variant histologies in IO trials. Read more

    Poništi
  13. 23. sij

    At the Summit, our employees at FMI gathered to discuss women’s professional and personal development, , and , and what that looks like at Foundation Medicine.

    Poništi
  14. 20. sij

    may help identify effective targeted treatment for those with . Two common subtypes, cervical adenocarcinoma & squamous cell carcinoma, are known to have targetable genomic mutations. Learn more:

    Poništi
  15. proslijedio/la je Tweet
    16. sij

    Volunteers from helped with our Clothing Collaborative yesterday, which provides business attire for job seekers at no charge. Thank you! You made a difference!

    Poništi
  16. proslijedio/la je Tweet
    14. sij

    This news is very encouraging, and I believe show the progress being made by cancer research and precision medicine. I’m hopeful to see future results beyond 2017 due to the recent advances in immunotherapy!

    Poništi
  17. 13. sij

    Partnerships are paving the way for improved patient options. Read more from our CEO :

    Poništi
  18. 13. sij

    Today we announced the appointment of Ritesh (Tesh) Khullar as Chief Commercial Officer. Welcome to !

    Poništi
  19. proslijedio/la je Tweet
    7. sij

    An incredible story about patient advocacy in its many forms. Thank you for all you do as a patient advocate!

    Poništi
  20. 6. sij

    Our Chief Scientific Officer joined us at the first-ever Summit and shared her thoughts on the importance of and the power of having a diversified team.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·